Literature DB >> 19135107

Barrier properties of mucus.

Richard A Cone1.   

Abstract

Mucus is tenacious. It sticks to most particles, preventing their penetration to the epithelial surface. Multiple low-affinity hydrophobic interactions play a major role in these adhesive interactions. Mucus gel is also shear-thinning, making it an excellent lubricant that ensures an unstirred layer of mucus remains adherent to the epithelial surface. Thus nanoparticles (NP) must diffuse readily through the unstirred adherent layer if they are to contact epithelial cells efficiently. This article reviews some of the physiological and biochemical properties that form the mucus barrier. Capsid viruses can diffuse through mucus as rapidly as through water and thereby penetrate to the epithelium even though they have to diffuse 'upstream' through mucus that is being continuously secreted. These viruses are smaller than the mucus mesh spacing, and have surfaces that do not stick to mucus. They form a useful model for developing NP for mucosal drug delivery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19135107     DOI: 10.1016/j.addr.2008.09.008

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  268 in total

Review 1.  Nanoparticle mediated non-covalent drug delivery.

Authors:  Tennyson Doane; Clemens Burda
Journal:  Adv Drug Deliv Rev       Date:  2012-06-01       Impact factor: 15.470

2.  The counterbalanced effect of size and surface properties of chitosan-coated poly(isobutylcyanoacrylate) nanoparticles on mucoadhesion due to pluronic F68 addition.

Authors:  Bénédicte Petit; Kawthar Bouchemal; Christine Vauthier; Madeleine Djabourov; Gilles Ponchel
Journal:  Pharm Res       Date:  2011-12-07       Impact factor: 4.200

Review 3.  Biological interactions of graphene-family nanomaterials: an interdisciplinary review.

Authors:  Vanesa C Sanchez; Ashish Jachak; Robert H Hurt; Agnes B Kane
Journal:  Chem Res Toxicol       Date:  2011-10-21       Impact factor: 3.739

4.  Drug Release and Targeting: the Versatility of Polymethacrylate Nanoparticles for Peroral Administration Revealed by Using an Optimized In Vitro-Toolbox.

Authors:  Susanne Beyer; Aline Moosmann; Astrid S Kahnt; Thomas Ulshöfer; Michael J Parnham; Nerea Ferreirós; Sylvia Wagner; Matthias G Wacker
Journal:  Pharm Res       Date:  2015-07-28       Impact factor: 4.200

5.  An exploration of the microrheological environment around the distal ileal villi and proximal colonic mucosa of the possum (Trichosurus vulpecula).

Authors:  Y F Lim; M A K Williams; R G Lentle; P W M Janssen; B W Mansel; S A J Keen; P Chambers
Journal:  J R Soc Interface       Date:  2013-02-06       Impact factor: 4.118

6.  Nanoparticle diffusion in respiratory mucus from humans without lung disease.

Authors:  Benjamin S Schuster; Jung Soo Suk; Graeme F Woodworth; Justin Hanes
Journal:  Biomaterials       Date:  2013-02-04       Impact factor: 12.479

7.  Nanoparticle penetration of human cervicovaginal mucus: the effect of polyvinyl alcohol.

Authors:  Ming Yang; Samuel K Lai; Tao Yu; Ying-Ying Wang; Christina Happe; Weixi Zhong; Michael Zhang; Abraham Anonuevo; Colleen Fridley; Amy Hung; Jie Fu; Justin Hanes
Journal:  J Control Release       Date:  2014-07-29       Impact factor: 9.776

Review 8.  Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.

Authors:  Kwang-Chul Kwon; Dheeraj Verma; Nameirakpam D Singh; Roland Herzog; Henry Daniell
Journal:  Adv Drug Deliv Rev       Date:  2012-10-23       Impact factor: 15.470

Review 9.  Current state and challenges in developing oral vaccines.

Authors:  Julia E Vela Ramirez; Lindsey A Sharpe; Nicholas A Peppas
Journal:  Adv Drug Deliv Rev       Date:  2017-04-22       Impact factor: 15.470

Review 10.  Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.

Authors:  Oljora Rezhdo; Lauren Speciner; Rebecca Carrier
Journal:  J Control Release       Date:  2016-08-09       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.